Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
boston
6
×
boston blog main
boston top stories
investing
6
×
life sciences
national blog main
national top stories
6
×
clinical trials
deals
fda
startups
medical devices
roche
san francisco blog main
san francisco top stories
venture capital
allosteric
antisense oligonucleotide
ascension ventures
atlas venture
atopic dermatitis
atrial fibrillation
autoimmune disorders
avapritinib
benzodiazepines
biofourmis
biogen
biovotion
blackstone group
blackstone life sciences
blueprint medicines
boston scientific
brace pharma
chugai pharmaceutical
cleva pharma
clinical trial
columbia university
cormorant asset management
cryterion medical
What
medicines
digital
million
new
startup
therapeutics
turn
acquire
adding
address
adds
ago
aiming
aims
allosteric
analytics
approval
atrial
backed
biofourmis
blueprint
boston
business
cancer
candidate
cause
ceo
clinic
clinical
closed
company
continues
cryterion
currently
data
deal
device
devices
disease
drug
Language
unset
Current search:
photo
×
boston
×
" national top stories "
×
investing
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion